Leishmaniasis- On the Verge of Elimination in SEA Region - Abstract
Leishmaniasis or Kala-azar is characterized by prolonged fever, splenomegaly and anemia. Post-kala-azar Dermal Leishmaniasis (PKDL) is considered as a complication of the disease. Stibogluconate, a drug which once was the cornerstone of therapy, became ineffective with drug resistance of about 60% in Bihar, India. Miltefosine, Paromomycin, Amphotericin B and Lipid Amphotericin B are drugs which may be used to treat VL. VL elimination from India, Nepal and Bangladesh undertaken in 2005 is progressing well.